2.5. Cells Transfection with mRNA-GFP

LK Larisa I. Karpenko
AR Andrey P. Rudometov
SS Sergei V. Sharabrin
DS Dmitry N. Shcherbakov
MB Mariya B. Borgoyakova
SB Sergei I. Bazhan
EV Ekaterina A. Volosnikova
NR Nadezhda B. Rudometova
LO Lyubov A. Orlova
IP Inna A. Pyshnaya
BZ Boris N. Zaitsev
NV Natalya V. Volkova
MA Mamedyar Sh. Azaev
AZ Anna V. Zaykovskaya
OP Oleg V. Pyankov
AI Alexander A. Ilyichev
request Request a Protocol
ask Ask a question
Favorite

HEK293T cells were grown in six-well tissue culture plates (Costar) with modified DMEM medium (Sigma-Aldrich, St. Louis, MI, USA) supplemented with 10% FBS (HyClone) and 50 mg/mL gentamicin. Medium (250 µL) containing either 2 µg of mRNA-GFP in PGS envelope or 2 µg of mRNA-GFP in liposomes from Lipofectamine 3000 (ThermoFisher, Waltham, MA, USA) was added to the wells of a culture plate with a monolayer of 70%–80% confluent cells. The control well was injected with 2 μg of “naked” mRNA-GFP. The cell plate was placed in a 37 °C CO2 incubator and incubated for 4 h. After that, the culture medium was replaced with a fresh one and the incubation continued for 24 h. The results were visualized using an Olympus CKX53 microscope or flow cytometry. To determine GFP expression levels, 20,000 events per sample gated on single cells were acquired on a Ze5 flow cytometer (Bio-Rad Laboratories Inc., Hercules, CA, USA) and analyzed using FlowJo software.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

0/150

tip Tips for asking effective questions

+ Description

Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.

post Post a Question
0 Q&A